type 1 diabetes

Lexicon to lay off 50% of field force as it prioritizes heart failure drug, potential US diabetes launch
Fierce Pharma
Wed, 08/14/24 - 11:03 am
Lexicon Pharmaceuticals
type 1 diabetes
sotagliflozin
layoffs
restructuring
Diamyd Medical to continue Phase III trial of type 1 diabetes treatment
Clinical Trials Arena
Wed, 07/31/24 - 10:23 am
Diamyd Medical
clinical trials
Diamyd
type 1 diabetes
Novo’s once-weekly insulin rejected by FDA
BioPharma Dive
Thu, 07/11/24 - 11:36 am
Novo Nordisk
insulin
Icodec
once-weekly insulin
FDA
type 1 diabetes
Lexicon Pharmaceuticals Resubmits Sotagliflozin NDA for Type 1 Diabetes
Stock Titan
Fri, 06/21/24 - 11:15 am
Lexicon Pharmaceuticals
type 1 diabetes
FDA
sotagliflozin
Novo Nordisk’s Once-Weekly Insulin Loses FDA Adcomm Vote for Type 1 Diabetes
BioSpace
Tue, 05/28/24 - 11:00 am
Novo Nordisk
insulin
insulin icodec
type 1 diabetes
Cell therapy fails to slow early type 1 diabetes, but safety is established
Stat
Wed, 05/8/24 - 11:00 pm
type 1 diabetes
cell therapy
Vertex Pharma Obtains Exclusive License To TreeFrog's Cell Manufacturing Technology, C-Stem
NASDAQ.com
Tue, 04/23/24 - 09:51 pm
Vertex Pharmaceuticals
TreeFrog Therapeutics
cell therapy
type 1 diabetes
FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Type 1 Diabetes Treatment
BioSpace
Tue, 03/19/24 - 09:22 pm
FibroBiologics
fibroblasts
type 1 diabetes
FDA fast tracks Diamyd’s immunotherapy for managing type 1 diabetes
Clinical Trials Arena
Thu, 02/15/24 - 07:15 pm
Diamyd
FDA
fast track
type 1 diabetes
Two Patient Deaths Force Vertex to Pause Diabetes Trial
BioSpace
Mon, 01/8/24 - 11:31 am
Vertex Pharmaceuticals
type 1 diabetes
VX-880
patient deaths
clinical trials
Trial finds Lilly’s Olumiant could treat type 1 diabetes
Pharmaphorum
Thu, 12/7/23 - 11:00 am
Eli Lilly
olumiant
type 1 diabetes
Vertex Presents Positive, Updated VX-880 Results From Ongoing Phase 1/2 Study in Type 1 Diabetes at the European Association for the Study of Diabetes 59th Annual Meeting
Businesswire
Tue, 10/3/23 - 07:32 pm
Vertex Pharmaceuticals
VX-880
clinical trials
type 1 diabetes
After treatment with semaglutide, people with newly diagnosed type 1 diabetes needed little or no insulin
Medical News Today
Sun, 09/10/23 - 08:03 pm
Novo Nordisk
Ozempic
semaglutide
type 1 diabetes
After First Approval, Experts Point to Barriers in Cell Therapy for Type 1 Diabetes
BioSpace
Thu, 07/13/23 - 10:11 am
CellTrans
Lantidra
type 1 diabetes
cell therapy
Eli Lilly
Siglion Therapeutics
FDA blesses CellTrans' Lantidra, the first cell therapy for Type 1 diabetes
Fierce Pharma
Thu, 06/29/23 - 11:24 am
CellTrans
Lantidra
donislecel
cell therapy
type 1 diabetes
Sernova reports positive interim data for Cell Pouch System
Drug Delivery Business
Tue, 06/27/23 - 10:33 pm
Sernova
Cell Pouch System
type 1 diabetes
Medtech
AstraZeneca Teams Up With Startup Quell in Type 1 Diabetes, IBD Cell Therapy Pact
MedCity News
Fri, 06/9/23 - 11:52 am
AstraZeneca
Quell Therapeutics
type 1 diabetes
IBD
cell therapy
DiogenX SA raises €27.5M in Series A financing for type 1 diabetes work
European Biotechnology
Wed, 05/10/23 - 10:13 am
DiogenX
funding
type 1 diabetes
Sigilon focuses on type 1 diabetes, reduces spend on MPS-1 after letting CMO go
Endpoints
Wed, 03/15/23 - 09:24 pm
Siglion Therapeutics
type 1 diabetes
cell therapy
Canadian royalty investor buys into first-of-its-kind Type 1 diabetes drug
BioPharma Dive
Fri, 03/10/23 - 09:53 am
DRI Healthcare Trust
type 1 diabetes
Macrogenics
Tzield

Pages